Influenza Vaccines Market: How Is Improving Vaccine Effectiveness Driving Innovation Investment?
Influenza vaccine effectiveness research and innovation — the ongoing investment in understanding and improving influenza vaccine effectiveness from the currently modest average forty to sixty percent effectiveness — drives the commercial innovation agenda that motivates development of cell-based, recombinant, adjuvanted, and ultimately universal influenza vaccines, with the...
0 Commenti 0 condivisioni 6 Views 0 Anteprima